Medtronic, Smith & Nephew & more: 9 device company mergers, acquisitions and agreements

Mackenzie Garrity -   Print  |

Here are nine device company mergers, acquisitions and agreements.

Tissue Regenix acquired CellRight Technologies in a $30 million deal.


Medtronic acquired Covidien for around $49.9 billion in 2015 and the combined company became Medtronic plc.


Emerging Implant Technologies acquired a portfolio of patents from Morgan P. Lorio, MD, of Nashville, Tenn.-based Hughston Clinic Orthopaedics.


DePuy Synthes signed an agreement with JointPoint to co-market proprietary software for the JointPoint navigation system.


Medtronic entered into the next phase of its strategic partnership with Mazor Robotics, making a third investment in the company.


Stryker finalized its Novadaq Technologies acquisition for $701 million. They announced plans to purchased Novadaq Technologies in June.


ApiFix entered into an exclusive distribution agreement with Joint Solutions Alliance Corp. in Canada.


Smith & Nephew signed a three-year partnership with Imperial College London to develop enhanced surgical techniques relating to ligament function, biomechanics and knee soft tissue injuries.


NuVasive acquired Vertera Spine, a medical device company focused on interbody implants using patented porous polyetheretheketone technology.


More articles on devices and implants:
How self-funded health plans boost patient satisfaction with medical innovation
Amedica adjourns stockholder special meeting — 5 takeaways
Medtronic receives recognition for social responsibility: 5 takeaways

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers